1 story in the last 7 days
The latest infinite epigenetics news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks infinite epigenetics across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Murchinson, a Nano Dimension shareholder with 7.4% of shares, criticized the board's decision to pursue a transaction with Infinite Epigenetics. The firm called the deal a misallocation of resources that would dilute existing shareholders. Murchinson also noted the conference call offered no shareholder Q&A opportunity.
Summaries by ByteBrief